Aspirine Sensitive Rhinosinusitis is Associated with Reduced E-prostanoid 2(EP2) Receptor Expression on Nasal Mucosal Inflammatory Cells

S. Ying,Q. Meng,G. Scadding,A. Parikh,C.J. Corrigan,T.H. Lee

DOI: https://doi.org/10.1016/j.jaci.2005.12.727

IF: 14.29

2006-01-01

Journal of Allergy and Clinical Immunology

Abstract:RATIONALE: Impaired “braking” of inflammatory cell cysteinyl leukotriene production by PGE2 has been implicated in the pathogenesis of aspirin exacerbated airways disease, but the mechanism is obscure. PGE2 acts via G-protein-coupled receptors, EP1-4, but there is little information on the expression of PGE2 receptors in this condition. To address the hypothesis that expression of one or more EP receptors on nasal mucosal inflammatory cells is deficient in patients with aspirin sensitive (AS), as compared with non-aspirin sensitive (NAS) polypoid rhinosinusitis. METHODS: Using specific antibodies, immunohistochemistry and image analysis, we measured, the expression of EP1-4 in sections of nasal biopsies from patients with AS (n=12) and NAS (n=10) polypoid rhinosinusitis and normal controls (n=9). Double staining was employed to phenotype inflammatory leukocytes expressing EP1 and EP2. RESULTS: Global mucosal expression of EP1 and EP2, but not EP3 or EP4 immunoreactivity was significantly elevated in AS and NAS rhinosinusitis as compared with controls (p<0.03). This was attributable principally to elevated epithelial expression. In contrast, the percentages of neutrophils, mast cells, eosinophils and T cells expressing EP2, but not EP1 were significantly reduced (p≤0.04) in the AS, as compared with NAS patients. CONCLUSIONS: The data are consistent with a possible role for PGE2 in mediating epithelial repair in rhinitis and asthma. Since PGE2 exerts a range of inhibitory actions on inflammatory leukocytes via the EP2 receptor, its reduced expression in AS rhinosinusitis may be partly responsible for the increased inflammatory infiltrate and production of cysteinyl leukotriene which characterises AS disease.